HomeCYCN • NASDAQ
Cyclerion Therapeutics Inc
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 93.00K | — |
Operating expense | 1.71M | 33.62% |
Net income | -324.00K | 75.49% |
Net profit margin | -348.39 | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.01M | -34.48% |
Total assets | 9.37M | -6.91% |
Total liabilities | 800.00K | -37.60% |
Total equity | 8.57M | — |
Shares outstanding | 3.20M | — |
Price to book | 1.09 | — |
Return on assets | -43.50% | — |
Return on capital | -48.18% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -324.00K | 75.49% |
Cash from operations | -503.00K | 54.52% |
Cash from investing | — | — |
Cash from financing | -130.00K | — |
Net change in cash | -633.00K | 42.87% |
Free cash flow | -1.35M | -108.63% |
Previous close
$3.04
Day range
$2.70 - $3.17
Year range
$1.27 - $9.47
Market cap
9.68M USD
Avg Volume
27.10K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2018
Website
Employees
1
